Gilead Sciences, Inc.
METHODS FOR TREATING HEPATITIS B VIRUS INFECTIONS USING NS5A, NS5B OR NS3 INHIBITORS

Last updated:

Abstract:

Provided are methods for treating hepatitis B virus infections by administering a NS5A inhibitor, NS5B3 inhibitor, a NS3 inhibitor, or combinations thereof.

Status:
Application
Type:

Utility

Filling date:

11 May 2017

Issue date:

21 Apr 2022